Blood Flow Restriction on Functional Mobility in Pre-frail Older Adults

November 23, 2023 updated by: Pei-Yun Lee, National Cheng Kung University

Effect of Blood Flow Restriction Resistance Exercise on Functional Mobility in Pre-Frail Older Adults

This study investigates the effect of blood flow restriction with resistance exercise on functional mobility in pre-frail older adults. It is hypothesized that receiving resistance exercise with blood flow restriction will exhibit better improvement on functional mobility than only receiving resistance exercise in pre-frail older adults.

Study Overview

Detailed Description

Participants aged over 65 years old with less than two items positive of Fried frailty phenotype assessment result will be recruited. The participants will be randomly assigned to two training groups, blood flow restriction resistance exercise and traditional resistance exercise. Both groups will receive the training 30 minutes/session, two sessions/week for six weeks. Muscle strength of the lower extremities and functional mobility tests will be used to assess outcomes at pre-training, 3-week after training, post-training, and one-month and two-month follow-up.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 704
        • Department of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 95 years (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged over 65 years old
  • Fried frailty index fulfill 1-2 criteria
  • Able to walk 6 meters independently
  • Able to understand and follow ≥ 3 instructions

Exclusion Criteria:

  • Severe hypertension (>180/110mmHg)
  • Peripheral neuropathy
  • History of deep-vein thrombosis (DVT)
  • Cardiovascular diseases (i.e. Heart failure NYHA Classification III or IV, myocardial infarction, pulmonary hypertension, coronary artery stenosis)
  • Neuromuscular diseases (i.e. Stroke, Parkinsons' disease)
  • History of resisted exercise training program within the last 6 months before screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Resistance exercise with blood flow restriction
Blood flow restriction on the thigh of the dominant leg will be used in combination with resistance exercise.
Active Comparator: Control
Traditional resistance exercise
Resistance exercise mainly on the lower extremities will be executed by carrying weight according to each participant's tolerance while performing certain movements, such as side step-up, sit-to-stand, and tip-toe-standing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Timed-Up and Go (TUG) test
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Timed-Up and Go test
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Change of 30 seconds sit to stand
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
30 seconds sit to stand test
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Change of muscle strength of the lower extremities
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Muscle strength of bilateral hip flexors, knee extensors, ankle dorsiflexors and plantarflexors
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of one-repetition maximum
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
One-repetiton maximum of side step-ups
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Change of muscle mass
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Muscle mass of the upper and lower extremities and trunk
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Change of hand grip strength
Time Frame: Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention
Bilateral grip strength
Before intervention, 3 and 6 weeks after intervention, and one- and two-month follow ups after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2020

Primary Completion (Actual)

October 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

January 10, 2022

First Submitted That Met QC Criteria

January 25, 2022

First Posted (Actual)

January 26, 2022

Study Record Updates

Last Update Posted (Actual)

November 27, 2023

Last Update Submitted That Met QC Criteria

November 23, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A-BR-110-075

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Resistance exercise on the lower extremities with blood flow restriction

Subscribe